ROLE OF CD14 AND OTHER LPS RECEPTORS IN ENDOTOXIC SHOCK
ROLE OF CD14 AND OTHER LPS RECEPTORS IN ENDOTOXIC SHOCK
批准号:
7315275
负责人:
Sanna M Goyert
金额:
$39.4万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1989
资助国家:
美国
项目状态:
已结题
起止时间:
1989-01-01 至 2007-12-30
关键词:
CD14 moleculeEscherichia coliStaphylococcus aureusantigen receptorsbacteria infection mechanismbacterial antigensbacterial geneticsbacterial proteinsdisease /disorder modelendotoxinsgene expressiongene targetinggram negative bacteriagram positive bacteriahost organism interactioninflammationlaboratory mouselipopolysaccharidesmicroorganism immunologymolecular pathologyprotein structurereceptor expressionseptic shocktissue /cell culturevirulence
中文摘要
描述(来自申请人摘要的逐字逐句)
重点是进一步阐明CD 14影响细胞增殖的机制。
炎症反应。具体目标1:确定联合国的相对作用
CD 14:LPS在细菌性病原体休克反应中的相互作用
各种毒力因子。我们之前已经证明,CD 14缺陷小鼠
对LPS和E.大肠杆菌0111。我们
假设是某些革兰氏阴性菌将主要诱导休克
通过CD 14:LPS途径,而其他细菌具有不同的耐受性,
这些因素将通过CD 14非依赖性机制诱导休克。为了验证这一
假设,我们将首先研究CD 14缺陷和正常的休克反应
小鼠与一组特征良好的E.表达确定毒力的大肠杆菌
决定因素接下来,我们将测试CD 14:LPS相互作用在一个细胞中的作用。
盲肠结扎穿孔致休克腹膜炎模型。最后我们
将使用口服休克模型来检查CD 14在对
利用独特机制逃避宿主免疫的细胞内生物
防御这些研究将扩大我们对
CD 14:LPS在细菌诱导休克中的相互作用将开始阐明
CD 14的作用机制:LPS介导的休克与CD 14非依赖性
冲击.具体目标2:确定CD 14:LPS相互作用的相对作用
局部感染。我们认为,运作系统模型的机制
will also也operate操作on the local本地level水平.也就是说,这些细菌
CD炎症!14-缺陷小鼠会引起局部炎症反应
在CD 14-/-小鼠中,与正常小鼠相似;那些不
在CD 14缺陷小鼠中引起休克不会引起组织损伤,
迅速清除。这些实验的结果应能补充
冲击模型,并导致对机制的进一步理解
调节这些细菌的毒力及其在炎症中的作用。具体
目的3:探讨可溶性CD 14(sCD 14)在感染性休克和局部缺血中的作用。
由LPS和各种细菌(革兰氏阴性,
革兰氏阳性)。研究表明,有两种激活途径,
LPS;一种通过膜CD 14刺激,一种通过另一种刺激
途径,需要一个复杂的性能网站。
英文摘要
DESCRIPTION (Verbatim from the applicant's abstract) The studies proposed will
focus on further elucidating mechanisms through which CD14 influences the
inflammatory response. Specific Aim 1: To define the relative role of the
CD14:LPS interaction in the shock response to bacterial pathogens posessing
various virulence fqactors. We have previously shown that CD14-deficient mice
are highly resistant to the lethal effects of LPS and E. Coli 0111. Our
hypothesis is that some Gram-negative bacteria will induce shock predominently
via the CD14:LPS pathway while other bacteria having different virulance
factors will induce shock via CD14 independent mechanisms. To test this
hypothesis, we will first study the shock response of CD14-deficient and normal
mice to a well characterized panel of E. coli expressing defined virulence
determinants. Next, we will test the role of the CD14:LPS interaction in a
peritonitis model of shock induced by cecal ligation and puncture. Finally, we
will use an oral model of shock to examine the role of CD14 in the response to
intracellular organisms that use unique mechanisms to evade the host immune
defense. These studies will expand our understanding of the relative roleof the
CD14:LPS interaction in shock induced by bacteria and will begin to elucidate
the mechanisms operating in CD14:LPS mediated shock versus CD14-independent
shock. Specific Aim 2: To define the relative role of the CD14:LPS interaction
in local infection. We believe that the mechanisms operating systemic models
will also operateon the local level. That is, those bacteria which cause
inflammation in CD!14-deficient mice will cause a local inflammatory response
in CD14-/- mice, similar to that of normal mice; those bacteria which do not
cause shock in CD14-deficient mice will not cause tissue damage and will be
quickly cleared. The results from these experiments should complement those in
the shock model and lead to an enhanced understandingf of the mechanisms
regulating virulence of these bacteria and their role im imflammation. Specific
Aim 3: To determine the role of soluble CD14 (sCD14) in septic shock and local
inflammation induced by LPS and various bacteria (Gram-negative,
Gram-positive). Studies suggest that there are two pathways for activation with
LPS; One that stimulates via membrane CD14 and one that stimulates via another
pathway and requires a complex of performance sites.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CHARACTERIZATION OF THE LPS RECEPTOR FOR ACUTE PHASE
-
批准号:6386492
-
项目类别:
-
资助金额:$18.45万
-
财政年份:2000
-
负责人:Sanna M Goyert
-
依托单位:
CHARACTERIZATION OF THE LPS RECEPTOR FOR ACUTE PHASE
-
批准号:6194383
-
项目类别:
-
资助金额:$18.16万
-
财政年份:2000
-
负责人:Sanna M Goyert
-
依托单位:
CHARACTERIZATION OF THE LPS RECEPTOR FOR ACUTE PHASE
-
批准号:6520033
-
项目类别:
-
资助金额:$18.45万
-
财政年份:2000
-
负责人:Sanna M Goyert
-
依托单位:
MOLECULAR ANALYSIS OF MACROPHAGE ACTIVATION VIA LBP--LPS
-
批准号:2184577
-
项目类别:
-
资助金额:$11.21万
-
财政年份:1992
-
负责人:Sanna M Goyert
-
依托单位:
MOLECULAR ANALYSIS OF MACROPHAGE ACTIVATION VIA LBP:LPS
-
批准号:3306655
-
项目类别:
-
资助金额:$11.54万
-
财政年份:1992
-
负责人:Sanna M Goyert
-
依托单位:
MOLECULAR ANALYSIS OF MACROPHAGE ACTIVATION VIA LBP:LPS
-
批准号:3306656
-
项目类别:
-
资助金额:$10.98万
-
财政年份:1992
-
负责人:Sanna M Goyert
-
依托单位:
CD14 AND OTHER LPS RECEPTORS AND ENDOTOXIN SHOCK
-
批准号:2062363
-
项目类别:
-
资助金额:$5.12万
-
财政年份:1989
-
负责人:Sanna M Goyert
-
依托单位:
CD14 AND OTHER LPS RECEPTORS AND ENDOTOXIN SHOCK
-
批准号:2671871
-
项目类别:
-
资助金额:$40.99万
-
财政年份:1989
-
负责人:Sanna M Goyert
-
依托单位:
ROLE OF CD14 AND OTHER LPS RECEPTORS IN ENDOTOXIC SHOCK
-
批准号:6693442
-
项目类别:
-
资助金额:$39.4万
-
财政年份:1989
-
负责人:Sanna M Goyert
-
依托单位:
Role of CD14 and other innate immune receptors in severe sepsis
-
批准号:7559603
-
项目类别:
-
资助金额:$38.5万
-
财政年份:1989
-
负责人:Sanna M Goyert
-
依托单位:
STRUCTURE AND FUNCTION OF MONOCYTE/GRANULOCYTE ANTIGENS
-
批准号:2062360
-
项目类别:
-
资助金额:$28.88万
-
财政年份:1989
-
负责人:Sanna M Goyert
-
依托单位:
STRUCTURE AND FUNCTION OF MONOCYTE/GRANULOCYTE ANTIGENS
-
批准号:3136343
-
项目类别:
-
资助金额:$25.95万
-
财政年份:1989
-
负责人:Sanna M Goyert
-
依托单位:
ROLE OF CD14 AND OTHER LPS RECEPTORS IN ENDOTOXIC SHOCK
-
批准号:6626337
-
项目类别:
-
资助金额:$39.4万
-
财政年份:1989
-
负责人:Sanna M Goyert
-
依托单位:
Role of CD14 and other innate immune receptors in severe sepsis
-
批准号:8213709
-
项目类别:
-
资助金额:$37.73万
-
财政年份:1989
-
负责人:Sanna M Goyert
-
依托单位:
CD14 AND OTHER LPS RECEPTORS AND ENDOTOXIN SHOCK
-
批准号:2062364
-
项目类别:
-
资助金额:$43.01万
-
财政年份:1989
-
负责人:Sanna M Goyert
-
依托单位:
Role of CD14 and other innate immune receptors in severe sepsis
-
批准号:7477431
-
项目类别:
-
资助金额:$38.5万
-
财政年份:1989
-
负责人:Sanna M Goyert
-
依托单位:
CD14 AND OTHER LPS RECEPTORS AND ENDOTOXIN SHOCK
-
批准号:2886524
-
项目类别:
-
资助金额:$42.63万
-
财政年份:1989
-
负责人:Sanna M Goyert
-
依托单位:
STRUCTURE AND FUNCTION OF MONOCYTE/GRANULOCYTE ANTIGENS
-
批准号:3136344
-
项目类别:
-
资助金额:$27.64万
-
财政年份:1989
-
负责人:Sanna M Goyert
-
依托单位:
STRUCTURE OF MONOCYTE AND GRANULOCYTE ANTIGENS
-
批准号:3136345
-
项目类别:
-
资助金额:$6.27万
-
财政年份:1989
-
负责人:Sanna M Goyert
-
依托单位:
ROLE OF CD14 AND OTHER LPS RECEPTORS IN ENDOTOXIC SHOCK
-
批准号:6844704
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1989
-
负责人:Sanna M Goyert
-
依托单位:
国内基金
海外基金
登录
查看更多内容
asr基因调控酸诱导的Escherichia coli O157:H7形成VBNC状态的机制研究
-
批准号:32302245
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:潘寒姁
-
依托单位:
小肠中Escherichia coli分泌细菌毒素诱导肠屏障损伤及细菌易位在炎症性肠病中的机制研究
-
批准号:82371775
-
项目类别:面上项目
-
资助金额:46万元
-
批准年份:2023
-
负责人:朱慧媛
-
依托单位:
基于Escherichia coli O157:H7亚致死态细胞探究超高压与原儿茶酸协同杀菌机制
-
批准号:31871817
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2018
-
负责人:孙爱东
-
依托单位:
肠肝轴:从临床患者分离的肠道致病菌株Escherichia coli NF73-1对非酒精性脂肪性肝病的作用及机制研究
-
批准号:81873549
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2018
-
负责人:刘玉兰
-
依托单位:
高压二氧化碳诱导Escherichia coli O157:H7形成VBNC状态的分子机制
-
批准号:31571933
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2015
-
负责人:廖小军
-
依托单位:
超高压诱导牛肉中Escherichia coli O157:H7亚致死损伤及其修复研究
-
批准号:31371861
-
项目类别:面上项目
-
资助金额:15.0万元
-
批准年份:2013
-
负责人:江芸
-
依托单位:
高压二氧化碳诱导Escherichia coli O157:H7形成VBNC状态的机制
-
批准号:31371845
-
项目类别:面上项目
-
资助金额:15.0万元
-
批准年份:2013
-
负责人:廖小军
-
依托单位:
高密度二氧化碳致死Escherichia coli的相关蛋白质确证及其结构变化研究
-
批准号:31171774
-
项目类别:面上项目
-
资助金额:66.0万元
-
批准年份:2011
-
负责人:张德权
-
依托单位: